Results 31 to 40 of about 1,354,083 (149)

Muir-Torre syndrome - Treatment with isotretinoin and interferon alpha-2a can prevent tumour development [PDF]

, 2000
Muir-Torre syndrome is a genodermatosis in which multiple internal malignancies are associated with cutaneous sebaceous tumours and kerato-acanthomas. A 57-year-old man presented with multiple sebaceous tumours, kerato-acanthomas, verrucous carcinoma of ...
Graefe, Tim, Burgdorf, Walter H. C., Wollina, Uwe, Schulz, Hans-Joachim   +3 more
core   +1 more source

A rare extraocular sebaceous carcinoma mimicking primary ectopic breast cancer

Human Pathology: Case Reports, 2020
Sebaceous carcinoma (SC) is an aggressive malignancy derived from the sebaceous glands. SC is divided into two categories, ocular and extraocular. Extraocular SC is quite rare, and is also associated with the Muir-Torre syndrome, which is regarded as a ...
Yuri Noda, Yuko Nakanishi, Ayaka Izui, Hiroyo Takahashi, Chiya Oshiro, Hideo Inaji, Masaru Yamasaki   +6 more
doaj   +1 more source

Clustering of sebaceous gland carcinoma, papillary thyroid carcinoma and breast cancer in a woman as a new cancer susceptibility disorder: a case report

Journal of Medical Case Reports, 2009
Introduction Multiple distinct tumors arising in a single individual or within members of a family raise the suspicion of a genetic susceptibility disorder.
Newman Brian D, Maher Joseph F, Subauste Jose S, Uwaifo Gabriel I, Bigler Steven A, Koch Christian A   +5 more
doaj   +1 more source

Muir-Torre syndrome is a predictor of gastric cancer (clinical observation)

Современная наука и инновации
Muir-Torre syndrome is a hereditary autosomal dominant syndrome that belongs to HNPCC (Lynch syndrome), being its subspecies. The disease is associated with a high risk of developing colorectal cancer, as well as other cancers of the gastrointestinal ...
Yu. A. Dykhno, Yu. V. Karacheva, Yu. Yu. Vinnik, V. S. Tsikh   +3 more
doaj   +1 more source

Muir-Torre syndrome

, 2004
Muir-Torre syndrome is a rare autosomal dominant disorder characterized by sebaceous neoplasms of skin and one or more malignancies of the visceral organs.
ELÇİOĞLU, HURİYE NURSEL
core   +1 more source

Muir-Torre syndrome

, 2005
Muir-Torre syndrome is an autosomal-dominant skin condition of genetic origin, characterised by tumours of the sebaceous gland or keratoacanthoma. that are associated with visceral malignant diseases.
PONZ DE LEON, Maurizio, PONTI, Giovanni
core   +1 more source

Muir-Torre Syndrome: case report and molecular characterization

, 2014
CONTEXT: Muir-Torre syndrome is a rare autosomal dominant genodermatosis caused by mutations in the mismatch repair genes. It is characterized by the presence of sebaceous skin tumors and internal malignancies, affecting mainly the colon, rectum and ...
Jorge Munoz (12468694), Carolina Alejandra Rios (12798851), Ricardo Villalon (12798854), Monica Acuna (12798857), Lucia Cifuentes (12798860)   +4 more
core   +1 more source

Sebaceous neoplasms: Just the thin end of the wedge

Clinical Case Reports, 2020
The presence of sebaceous neoplasm should alert physicians to thoroughly investigate for underlying malignancies. Awareness on MTS should be raised within physicians, since this may be just the thin end of the wedge.
Aikaterini Kyriakou, Nikiforos Galanis, Eliza Stavride, Aikaterini Patsatsi, Elizabeth Lazaridou, Eleftherios Tsiridis   +5 more
doaj   +1 more source

The liver: another organ involved in Muir Torre syndrome?

, 2011
Muir Torre syndrome is a rare autosomal dominant cancer-predisposing syndrome characterized by the occurrence of sebaceous gland neoplasms and/or keratoacanthomas associated with visceral malignancies that belong to the spectrum of hereditary non ...
Mescoli C, ALAIBAC, MAURO SALVATORE ALESSANDRO, GATTA, ANGELO, Pizzi M, Piano S, Cavallin M, Pilati P, Romano A, ANGELI, PAOLO, Morando F   +9 more
core   +1 more source

The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics

Clinical Genetics, Volume 110, Issue 3, Page 389-401, September 2026.
The WHO Classification of Tumours underpins the diagnosis of neoplastic conditions. The new WHO classification of genetic tumour syndromes (GTS) provides international standards for their diagnosis. This diagram highlights the chromosomal distribution of the genes involved in the GTS covered in this classification.
Ian A. Cree, Mark J. Arends, Joseph D. Khoury, Erika R. E. Denton, Anthony J. Gill, Alexander J. Lazar, Ian M. Frayling, Stefan M. Pfister, Mark A. Rubin, Katia R. M. Leite, Raymond Dalgleish, Elspeth A. Bruford, Sharon E. Plon, Ada Hamosh, Michael Francis Walsh, Gabrielle Goldman‐Lévy, Harshima Wijesinghe, William D. Foulkes, Dilani Lokuhetty   +18 more
wiley   +1 more source